Global Antinuclear Antibody Tests Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431908
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere, Inc.
  • Antibodies, Inc.
  • Biocom Biotech
  • Erba Diagnostics, Inc.
  • Euroimmun AG
  • MORE
Antinuclear Antibody Tests Market - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025, the global antinuclear antibody tests market was valued at US$ 649 Mn in 2016, and is expected to reach US$ 1,588.7 Mn by 2025, expanding at a CAGR of 9.8% from 2017 to 2025

Market Insights

An antinuclear antibody tests (ANA) are used to evaluate quantity and pattern of antibodies in the blood. It is used to evaluate autoimmune disorders that might affect tissues and organ throughout systemic body. It is commonly used to diagnose rheumatoid arthritis, systemic lupus erythematosus (SLE), Sjögren syndrome, scleroderma and polymyositis. Usually any foreign body such as virus or bacteria if enters the body, would be destroyed by the immune system. In autoimmune disorder, body produces ANA as group of antibodies, as the immune system is not able to differentiate between "self" and "nonself." It targets the nucleus of the cell and destroys the tissue and the organ. Rising prevalence of autoimmune disorders, advancement in lab automation and use of novel biomarker are the key factors driving the growth of antinuclear antibody tests market

The global antinuclear antibody tests market is segmented by product type into reagent & assays kits, systems and software & services. Reagents and assay kits occupy the largest share of global antinuclear antibody tests market. The global antinuclear antibody tests market is segmented by technique type into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay and multiplex assay. Enzyme-Linked Immunosorbent Assay (ELISA) dominates the global antinuclear antibody tests market. By disease, global antinuclear antibody tests market is segmented into rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, scleroderma and other diseases. Rheumatoid arthritis currently occupies the largest market share of global antibody tests market due to rising prevalence of rheumatoid arthritis.

As of the current market scenario, North America dominated the global antinuclear antibody tests market followed by the Europe. Factors contributing to the growth of North America market includes increase in prevalence of autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus (SLE), growing introduction and availability of novel diagnostic tools and supportive reimbursement policies. Asia Pacific is the fastest growing regional market for antinuclear antibody tests.

Market Competition Assessment

Key players in the global antinuclear antibody test market are Alere, Inc., EUROIMMUN AG, ERBA Diagnostics, Inc., Trinity Biotech plc, Bio-Rad Laboratories, Inc., Immuno Concepts, Thermo Fisher Scientific, Inc., Antibodies, Inc., Inova Diagnostics, Zeus Scientific, Inc. and others.

Key Market Movements:
  • Rising awareness about autoimmune disorders and availability of novel diagnostic tools and kits also contribute to the growth of antinuclear antibody tests market
  • Prevalence of diagnosed autoimmune conditions is highest in EU-5 with 9%, followed by China and U.S. with 8% and 7% respectively. Autoimmune diseases is one of leading cause of mortality in developed countries. Thus rising prevalence of autoimmune disorder is the pivotal factor driving the growth of antinuclear antibody tests market
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere, Inc.
  • Antibodies, Inc.
  • Biocom Biotech
  • Erba Diagnostics, Inc.
  • Euroimmun AG
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Antinuclear Antibody Tests Market Portraiture
2.1.1. Global Antinuclear Antibody Tests Market, by Product Type, 2016
2.1.2. Global Antinuclear Antibody Tests Market, by Technique Type, 2016
2.1.3. Global Antinuclear Antibody Tests Market, by Disease Type, 2016
2.1.4. Global Antinuclear Antibody Tests Market, by Geography, 2016

Chapter 3. Antinuclear Antibody Tests: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Antinuclear Antibody Tests Market, by Product Type
4.3. Reagents & Assay Kits
4.4. Software & Services
4.5. Systems

Chapter 5. Global Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition: Global Antinuclear Antibody Tests Market, by Technique Type
5.3. ELISA
5.4. Immunofluorescence Assay
5.5. Multiplex Assay

Chapter 6. Global Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
6.1. Overview
6.2. Attractive Investment Proposition: Global Antinuclear Antibody Tests Market, by Disease Type
6.3. Rheumatoid Arthritis
6.4. Scleroderma
6.5. Systemic Lupus Erythematosus
6.6. Sjögren’s Syndrome
6.7. Other Diseases

Chapter 7. Global Antinuclear Antibody Tests Market, by Geography, 2015 - 2025 (US$ Mn)
7.1. Overview
7.2. North America Antinuclear Antibody Tests Market Analysis, 2015 - 2025
7.2.1. North America Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
7.2.2. North America Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
7.2.3. North America Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
7.2.4. North America Antinuclear Antibody Tests Market, by Country, 2015 - 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Antinuclear Antibody Tests Market Analysis, 2015 - 2025
7.3.1. Europe Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
7.3.2. Europe Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
7.3.3. Europe Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
7.3.4. Europe Antinuclear Antibody Tests Market, by Country, 2015 - 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. France
7.3.4.4. Rest of Europe
7.4. Asia Pacific Antinuclear Antibody Tests Market Analysis, 2015 - 2025
7.4.1. Asia Pacific Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
7.4.2. Asia Pacific Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
7.4.3. Asia Pacific Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
7.4.4. Asia Pacific Antinuclear Antibody Tests Market, by Country, 2015 - 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. India
7.4.4.4. Rest of APAC
7.5. Latin America Antinuclear Antibody Tests Market Analysis, 2015 - 2025
7.5.1. Latin America Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
7.5.2. Latin America Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
7.5.3. Latin America Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
7.5.4. Latin America Antinuclear Antibody Tests Market, by Country, 2015 - 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Antinuclear Antibody Tests Market Analysis, 2015 - 2025
7.6.1. MEA Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
7.6.2. MEA Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
7.6.3. MEA Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
7.6.4. MEA Antinuclear Antibody Tests Market, by Region, 2015 - 2025 (US$ Mn)
7.6.4.1. UAE
7.6.4.2. Saudi Arabia
7.6.4.3. South Africa
7.6.4.4. Rest of MEA

Chapter 8. Company Profiles
8.1. Alere, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Abbott Laboratories
8.3. Antibodies, Inc.
8.4. Bio-Rad Laboratories, Inc.
8.5. Biocom Biotech
8.6. Erba Diagnostics, Inc.
8.7. Euroimmun AG
8.8. HUMAN Diagnostics, Inc.
8.9. Immuno Concepts, Inc.
8.10. Inova Diagnostics, Inc.
8.11. Thermo Fisher Scientific, Inc.
8.12. Trinity Biotech Plc
8.13. Zeus Scientific, Inc.
8.14. Other Notable Players

List of Figures
Fig. 1 Antinuclear Antibody Tests: Market Segmentation
Fig. 2 Global Antinuclear Antibody Tests Market Share, by Product Type, 2016 (US$ Mn)
Fig. 3 Global Antinuclear Antibody Tests Market Share, by Technique Type, 2016 (US$ Mn)
Fig. 4 Global Antinuclear Antibody Tests Market Share, by Disease Type, 2016 (US$ Mn)
Fig. 5 Global Antinuclear Antibody Tests Market, by Geography, 2016 (Value %)
Fig. 6 Attractive Investment Proposition, by Geography
Fig. 7 Market Competition Landscape, by Key Players, 2016
Fig. 8 Global Antinuclear Antibody Reagents & Assay Kits Market, 2015 - 2025 (US$ Mn)
Fig. 9 Global Antinuclear Antibody Systems Market, 2015 - 2025 (US$ Mn)
Fig. 10 Global Antinuclear Antibody Software and Services Market, 2015 - 2025 (US$ Mn)
Fig. 11 Global Elisa Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 12 Global Immunofluorescence Assay Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 13 Global Multiplex Assay Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 14 Global Antinuclear Antibody Tests for Rheumatoid Arthritis Market, 2015 - 2025 (US$ Mn)
Fig. 15 Global Antinuclear Antibody Tests for Systemic Lupus Erythematosus Market, 2015 - 2025 (US$ Mn)
Fig. 16 Global Antinuclear Antibody Tests for Sjögren’s Syndrome Market, 2015 - 2025 (US$ Mn)
Fig. 17 Global Antinuclear Antibody Tests for Scleroderma Market, 2015 - 2025 (US$ Mn)
Fig. 18 Global Antinuclear Antibody Tests for Other Diseases Market, 2015 - 2025 (US$ Mn)
Fig. 19 U.S. Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 20 Canada Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 21 U.K. Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 22 Germany Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 23 France Antinuclear Antibody Tests Market, 2015-2025 (US$ Mn)
Fig. 24 Rest of Europe Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 25 Japan Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 26 China Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 27 India Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 28 Rest of Asia Pacific Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 29 Brazil Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 30 Mexico Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 31 Rest of Latin America Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 32 UAE Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 33 Saudi Arabia Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 34 South Africa Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)
Fig. 35 Rest of Middle East and Africa Antinuclear Antibody Tests Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 2 Global Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
Table 3 Global Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
Table 4 North America Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 5 North America Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
Table 6 North America Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
Table 7 North America Antinuclear Antibody Tests Market, by Country, 2015 - 2025 (US$ Mn)
Table 8 Europe Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 9 Europe Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
Table 10 Europe Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
Table 11 Europe Antinuclear Antibody Tests Market, by Country, 2015 - 2025 (US$ Mn)
Table 12 Asia Pacific Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025(US$ Mn)
Table 13 Asia Pacific Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025(US$ Mn)
Table 14 Asia Pacific Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025(US$ Mn)
Table 15 Asia Pacific Antinuclear Antibody Tests Market, by Country, 2015 - 2025(US$ Mn)
Table 16 Latin America Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025(US$ Mn)
Table 17 Latin America Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025(US$ Mn)
Table 18 Latin America Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025(US$ Mn)
Table 19 Latin America Antinuclear Antibody Tests Market, by Country, 2015 - 2025 (US$ Mn)
Table 20 Middle East and Africa Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 21 Middle East and Africa Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
Table 22 Middle East and Africa Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
Table 23 Middle East and Africa Antinuclear Antibody Tests Market, by Region, 2015 - 2025 (US$ Mn)
Table 24 Alere, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 25 Abbott Laboratories: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 26 Antibodies, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 27 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 28 Biocom Biotech: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 29 Erba Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 30 Euroimmun AG: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 31 HUMAN Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 32 Immuno Concepts, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 33 Inova Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 34 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 35 Trinity Biotech Plc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Table 36 Zeus Scientific, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Alere, Inc.
  • Abbott Laboratories
  • Antibodies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biocom Biotech
  • Erba Diagnostics, Inc.
  • Euroimmun AG
  • HUMAN Diagnostics, Inc.
  • Immuno Concepts, Inc.
  • Inova Diagnostics, Inc.
  • Thermo Fisher Scientific,
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll